• FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler. 

    , , ,

    Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…

    Read More...

  • ASPN-AAHS-ASRM meetings kick off 2024 Conference Season for PBC Biomed

    Brittney Martinez, VP of Business Development and Marketing and Gerard Insley, Chief Science Officer are pictured at the ASPN, AAHS and ASRM joint meeting in Nassau last week. This meeting provided an excellent opportunity for the team to connect with surgeon advisors, industry partners and current clients ahead of an exciting year. Update to follow…

    Read More...

  • 2024: A Transformative Year Ahead for PBC Biomed

    Driven by our dedicated team as well as our valued industry and academic partners, 2024 is set to become a transformative year for our commercialisation and developmental programmes. We would like to take this opportunity to thank our current partners and friends for your continued support and encouragement – we look forward to sharing further…

    Read More...

  • Canine ex vivo tarsal arthrodesis: Fixation by using a new bone tissue glue.

    Researchers from the Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden (SLU) and the Department of Surgery, BlÃ¥ Stjärnans Djursjukhus, Gothenburg, Sweden; Michael Pujari-Palmer, Odd Viking Höglund, Gustaf Svensson, and Tobias Per Otto Lundin, recently published a paper which examines the fixation capabilities of OsSticTM technology in a canine ex vivo tarsal…

    Read More...

  • Strengthening the Bond Part III at OTA 2023

    Thank you to our panel of surgeon experts for another great ‘Strengthening the Bond’ symposium at the Orthopaedic Trauma Association conference last week. They also supported us with product demonstrations at our stand for any attendees interested in learning more about one of most exciting technologies – OsStic. Pictured is Dr Tracey Watson using OsStic with a…

    Read More...

  • Successful OCP Workshop at Bioceramics33

    PBC Biomed CSO Gerard Insley is pictured in action during the dedicated #OCP Workshop at the Bioceramics 33 event in Solothurn, Switzerland on October 17th. The purpose of this workshop was to create a forum for the world’s leading experts and industrial representatives to share their latest advances in OCP R&D. Well done to the extended panel of experts who…

    Read More...

  • PBC Biomed Educational Symposium at the 2023 OTA Conference

    ,

    Join PBC Biomed for Part Two of the ‘Strengthening the Bond’ Symposium Series at the Orthopaedic Trauma Association Congress in Seattle, WA next week. Our global panel of surgeon experts consisting of Professor Peter Giannoudis, Dr Thomas A. (Toney) Russell MD, Dr Hassan Mir, MD, MBA and Dr John Tracy Watson, will focus on ‘A New Look at Biomaterials as Fixation Devices’. Date/Time: Friday…

    Read More...

  • PBC Biomed Company Day 2023

    The PBC Biomed Company Day 2023 was a great success, featuring live demonstrations of our most exciting technologies by R&D engineer Manikanda kumar (Mani) Subramanian, as well as a tour of the Limerick Military Barracks organised courtesy of Operations Director Robbie Kiely. A special thank you goes out to the students that joined us this year as part…

    Read More...

  • PBC Biomed Sponsor GMMDC Leadership Update & Reception

    Brittney Martinez, VP of Business Development and Marketing, is pictured speaking on PBC Biomed’s ‘Mission in Memphis’ at the Greater Memphis Medical Device Council (GMMDC) Leadership Update and Reception on August 22nd. The Executive Committee of the Board also provided an update on the strategic direction of the GMMDC and introduced the new Executive Director…

    Read More...

  • PBC Biomed attends OMTEC 2023

    The PBC BioMed team will be attending the 2023 OMTEC event in Chicago this June, to learn about the latest advancements within the orthopaedic manufacturing and technology space, as well as share information on our R&D and #contractmanufacturing capabilities.

    Read More...